SAVA
FILANA THERAPEUTICS, INC.
Key Financials
Revenue
$41.1M
0.0%
EPS (Diluted)
$-1.88
↓ 28.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 7/29/2026 | View on SEC |
| 8-K | 7/29/2026 | View on SEC |
| 8-K | 6/15/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| ARS | 4/28/2026 | View on SEC |
| DEF 14A | 4/28/2026 | View on SEC |
| 8-K | 4/28/2026 | View on SEC |
| 10-K | 3/12/2026 | View on SEC |
| 8-K | 3/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SAVA |
| Company Name | FILANA THERAPEUTICS, INC. |
| CIK | 1069530 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 512-501-2444 |